Clinical Trial Update: Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating human adipose-derived mesenchymal stem cells for critical limb ischemia in diabetic patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Diabetes Mellitus

Drugs mentioned

• Human adipose-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Critical Limb Ischemia (CLI), Diabetes | Phase 1, Phase 2 | Status: COMPLETED